Clinical Trials
443 trialsiROC
University College, London
Enhancing Readability of Lay Abstracts and Summaries for Medical Knowledge Using Generative Artificial Intelligence (BRIDGE AI 3)
University of Southern California
P3BC
Icahn School of Medicine at Mount Sinai
Holmium Laser En-Bloc Resection Versus Conventional Transurethral Resection of Bladder Tumors for Treatment of Non-muscle- Invasive Bladder Cancer
Beni-Suef University
Impact Advanced Recovery® for Radical Cystectomy (RC) Patients: a Pilot Study
University of Kansas Medical Center
VICKI
Institut Mutualiste Montsouris
IRIS
University of Pisa
Phase 2 Study of Pembrolizumab in Combination With Gemcitabine and Cisplatin as Neoadjuvant Therapy
UNC Lineberger Comprehensive Cancer Center
Recovery Support for Bladder Cancer Patients and Caregivers
Northwell Health
VISIOCYT2
Institut Paoli-Calmettes
COMPARISON OF OBTURATOR NERVE BLOCK TECHNIQUES IN TURBT
University of Gaziantep
Bristol Bladder Trial
University Hospitals Bristol and Weston NHS Foundation Trust
Image-Guided Radiation Therapy for Bladder-Cancer Patients Undergoing Radiotherapy and Concurrent Gemcitabine Chemotherapy
Memorial Sloan Kettering Cancer Center
NICSA
Aarhus University Hospital
GreenBladder - Early Detection of Bladder Cancer in Residents in Greenland Using a Urinary Marker and a Mobile Cystoscopy Unit
Aarhus University Hospital
MAINTAIN
Aarhus University Hospital
Study of CG0070 Combined With Nivolumab in Cisplatin Ineligible Patients With MIBC
H. Lee Moffitt Cancer Center and Research Institute
BGJ398 in Non-Muscle-Invasive Urothelial Carcinoma of the Bladder
Memorial Sloan Kettering Cancer Center
PREPARE
Institut Bergonié
Cryoablation With Pembrolizumab Or Avelumab In Urothelial Carcinoma
Massachusetts General Hospital
HYBRID
Institute of Cancer Research, United Kingdom
PERTINENCE
Institut Cancerologie de l'Ouest
QSCO
University Hospital, Toulouse
Evaluating Length of Treatment With PD-1/PD-L1 Inhibitor in Advanced Solid Tumors
University of Pittsburgh
Histopathological Findings in En-Bloc vs Conventional Transurethral Resection of Bladder Tumors.
Ain Shams University
Remote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported Outcomes
City of Hope Medical Center
ctDNA in Subjects With Muscle-invasive Bladder Cancer Treated With Trimodality Therapy
UNC Lineberger Comprehensive Cancer Center
Development of Multiphasic CT-based Delta-Radiomics Model for Predicting Postoperative Recurrence Risk in Bladder Cancer
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
SBCT
University of Zurich
WATCH
University of Pittsburgh
AYAConnect
UNC Lineberger Comprehensive Cancer Center
VESPER
University Hospital, Rouen
A Study of Pemigatinib in Non-muscle Invasive Bladder Cancer Patients With Recurrent Low- or Intermediate-Risk Tumors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
The Impact of Intelligent Nursing Based on Health Cloud Platform on Active Health Management of Urostomy Patients
Sir Run Run Shaw Hospital
MORE
Icahn School of Medicine at Mount Sinai
TEP-Vessie
Institut Bergonié
Pembrolizumab and Combination Chemotherapy Before Surgery for the Treatment of Muscle-Invasive Bladder Cancer
University of Washington
Clinical Registry for Oligometastic Disease, Consolidation Therapy, Debulking Prior to Chemotherapy, or Re-Irradiation
University of Texas Southwestern Medical Center
FIDURA
Sahlgrenska University Hospital
EARN
Washington University School of Medicine
Decision Making for Urinary Diversion in Patients With Bladder Cancer
University of Colorado, Denver
Prophylactic Antibiotics for Urinary Tract Infections After Robot-Assisted Radical Cystectomy
Roswell Park Cancer Institute
BLAST
Baylor College of Medicine
URODX-FGFR3
Institut de Cancérologie de Lorraine
Relationship Between Tumor Mutation Burden and Predicted Neo-antigen Burden in Patients With Advanced Melanoma or Bladder Cancer Treated With Nivolumab or Nivolumab Plus Ipilimumab (CA209-260)
Memorial Sloan Kettering Cancer Center
BOOST
University of Utah
BoBCaT
University Hospital, Rouen
PUBMIC (Prophylactic Use of Biologic Mesh in Ileal Conduit)
University of Southern California
CD155 in Bladder Cancer
Fudan University
CIMMIS
Fundacio Puigvert